Australia markets close in 43 minutes

Ironwood Pharmaceuticals, Inc. (IRWD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
12.67+0.32 (+2.59%)
At close: 4:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
413,024
389,523
428,413
346,639
298,276
Cost of revenue
897
3,136
23,875
32,751
19,097
Gross profit
412,127
386,387
404,538
313,888
279,179
Operating expenses
Research development
65,606
88,062
115,044
166,503
148,228
Selling general and administrative
123,614
140,003
172,450
241,291
233,123
Total operating expenses
189,220
228,065
287,494
415,905
387,565
Operating income or loss
222,907
158,322
117,044
-102,017
-108,386
Interest expense
30,192
29,478
36,602
37,724
36,370
Total other income/expenses net
-18,386
-21,487
-24,361
-145,618
25,708
Income before tax
175,042
108,861
58,943
-282,368
-116,937
Income tax expense
-333,814
2,685
-
-
-
Income from continuing operations
508,856
106,176
58,943
-282,368
-116,937
Net income
508,856
106,176
21,505
-282,368
-116,937
Net income available to common shareholders
508,856
106,176
21,505
-282,368
-116,937
Basic EPS
-
0.67
0.14
-1.85
-0.78
Diluted EPS
-
0.66
0.14
-1.85
-0.78
Basic average shares
-
159,427
153,607
152,634
148,993
Diluted average shares
-
160,655
156,023
152,634
148,993
EBITDA
-
141,903
101,125
-230,421
-65,950